You have 9 free searches left this month | to do more
Showing 1 - 25 of
40 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
G
Recruiting
  • Myelodysplastic Syndromes
  • Luspatercept
  • Hamburg, Germany
  • +4 more
2021-12-20
Dec 20, 2021
M
Recruiting
  • Myelodysplastic Syndromes
  • Miami, Florida
  • +5 more
2021-11-10
Nov 10, 2021
M
Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2022-01-19
Jan 19, 2022
C
Active, not recruiting
  • Thalassemia
  • Luspatercept
  • +2 more
  • Los Angeles, California
  • +13 more
2021-10-18
Oct 18, 2021
G
Not yet recruiting
  • MDS
  • Myelodysplastic Syndromes
  • Luspatercept Injection [Reblozyl]
  • Eprex
  • Amiens, France
  • +28 more
2021-12-20
Dec 20, 2021
A
Completed
  • Myelodysplastic Syndromes
  • Dresden, Germany
    Acceleron Investigative Site
2021-04-29
Apr 29, 2021
A
Completed
  • Anemia
  • Dresden, Germany
    Acceleron Investigative Site
2021-04-29
Apr 29, 2021
A
Completed
  • Beta-Thalassemia
  • Athens, Greece
  • +6 more
2021-05-17
May 17, 2021
C
Completed
  • Erythrocyte Transfusion
  • Beta-Thalassemia
  • Luspatercept
  • Placebo
  • Los Angeles, California
  • +72 more
2022-01-21
Jan 21, 2022
C
Completed
  • Myelodysplastic Syndromes
  • Luspatercept
  • Placebo
  • Stanford, California
  • +73 more
2021-11-19
Nov 19, 2021
C
Recruiting
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • Luspatercept
  • Los Angeles, California
  • +121 more
2020-11-30
Nov 30, 2020
N
Completed
  • Acute Myelogenous Leukemia
  • +6 more
  • This is a non-interventional study
  • Bakersfield, California
  • +19 more
2022-04-04
Apr 4, 2022
I
Active, not recruiting
  • Beta Thalassemia Intermedia
  • IONIS TMPRSS6-LRx
  • Camperdown, New South Wales, Australia
  • +20 more
2022-01-03
Jan 3, 2022
T
Recruiting
  • Iron Overload
  • San Antonio, Texas
    Mays Cancer Center, UT Health San Antonio
2021-06-22
Jun 22, 2021
C
Not yet recruiting
  • Myelodysplastic Syndromes
  • Beta-thalassemia
    • (no location specified)
    2021-07-13
    Jul 13, 2021
    M
    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Basking Ridge, New Jersey
    • +5 more
    2022-02-14
    Feb 14, 2022
    T
    Recruiting
    • Leukemia
    • +2 more
    • Enasidenib mesylat dose escalation
    • Palo Alto, California
      Stanford Cancer Institute
    2022-03-07
    Mar 7, 2022
    R
    Not yet recruiting
    • Low Risk Myelodysplastic Syndromes
    • R906289 Monosodium (R289 Na)
    • (no location specified)
    2022-03-25
    Mar 25, 2022